Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

"Beijing Sun-Novo Pharmaceutical Research Co., Ltd."Announcement on the Use of Certain Raised Funds to Increase the Capital of a Wholly-owned Subsidiary for the Implementation of Fundraising Investment Projects

· Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Use of Certain Raised Funds to Increase the Capital of a Wholly-owned Subsidiary for the Implementation of Fundraising Investment Projects

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A

All Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A news releases